Lead Author: Ralph Defronzo
BMJ Reprint "Study protocol for a prospective, multicenter study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone
Field Instruction:
- This is a sealed reprint that must remain sealed when handing out to HCPs
** Mandatory Sunshine Act reporting requires that this reprint be logged in Veeva when leaving behind with an HCP
FIELD USE:
- PRINT: MSLs and TLLs can Discuss and Leave Behind; CSS and KAM may leave behind with no discussion - if questions arise, please contact your MSL;
Corcept Materials Order Website
- DIGITAL: May not be shared digitally
- MAIL: Can be mailed to HCP office. Must include Disease Mailing Resource Letter (DSE-00738 AUG 2020)
